📰 Andreaf Wainer News
Page 23 - Andreaf Wainer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Andreaf Wainer. Real-time updates on events, politics, business and more.
February 27, 2024
Trustmark National Bank Trust Department cut its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 11,715 shares of the healthcare product maker’s stock after selling 250 shares during […]
February 27, 2024
Tower Research Capital LLC TRC increased its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 199.8% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 70,979 shares of the healthcare product maker’s stock after purchasing an additional 47,300 shares during the quarter. […]
February 27, 2024
Staley Capital Advisers Inc. reduced its position in Abbott Laboratories (NYSE:ABT – Free Report) by 48.6% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 11,214 shares of the healthcare product maker’s stock after selling 10,606 shares during the period. Staley Capital Advisers Inc.’s holdings in Abbott Laboratories were worth $1,086,000 at the end of […]
February 27, 2024
Tower Research Capital LLC TRC increased its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 199.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 70,979 shares of the healthcare product maker’s stock after buying an additional 47,300 shares during […]
February 27, 2024
Staley Capital Advisers Inc. cut its position in Abbott Laboratories (NYSE:ABT – Free Report) by 48.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,214 shares of the healthcare product maker’s stock after selling 10,606 shares during the quarter. Staley Capital […]
February 27, 2024
Tower Research Capital LLC TRC increased its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 199.8% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 70,979 shares of the healthcare product maker’s stock after purchasing an additional 47,300 shares during the quarter. […]
February 24, 2024
Parkside Financial Bank & Trust grew its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 41.7% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 12,867 shares of the healthcare product maker’s stock after purchasing an additional 3,785 shares during the […]
February 24, 2024
Parkside Financial Bank & Trust raised its position in Abbott Laboratories (NYSE:ABT – Free Report) by 41.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,867 shares of the healthcare product maker’s stock after acquiring an additional 3,785 shares during the […]
February 24, 2024
Parkside Financial Bank & Trust grew its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 41.7% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 12,867 shares of the healthcare product maker’s stock after purchasing an additional 3,785 shares during the […]
February 23, 2024
AlphaCore Capital LLC bought a new position in Abbott Laboratories (NYSE:ABT – Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 3,304 shares of the healthcare product maker’s stock, valued at approximately $320,000. Several other hedge funds and other institutional investors also recently […]